Breaking News, Promotions & Moves

Teva Names R. Ananth CEO for API Business

Ananth has over 34 years of experience leading global API businesses in external sales, internal operations, and in contract development and manufacturing.

Teva Pharmaceutical has appointed R. Ananthanarayanan (Ananth) CEO of its active pharmaceutical ingredient (API) business. Ananth will lead the API business starting November 27, 2023, and will be based out of Teva’s U.S. headquarters in Parsippany, NJ.   Ananth joins Teva with over 34 years of experience leading global API businesses in external sales, internal operations, and in contract development and manufacturing operations. He will lead Teva api through its transformation to a sta...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters